Remote Pharmacy Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: people who want low cash-pay compounded glp-1 with no subscription and free shipping
Remote Pharmacy is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Remote Pharmacy is a US direct-to-consumer telehealth service offering compounded GLP-1 weight-loss medication on a cash-pay basis with no subscriptions or hidden fees. Compounded semaglutide starts at 167 dollars per month, available as an injectable or a sublingual form, and compounded tirzepatide starts at 229.99 dollars per month, also with a tablet option. Patients pay only for their medication; the doctor consultation and shipping are provided free. Medication is made by 503A-certified compounding facilities that meet FDA standards. Support is available by phone and email.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Remote Pharmacy
MEDVi
Best for: patients who want the option to switch between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
Liv Body
Best for: compounded GLP-1 paired with a muscle-preservation supplement stack
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee GLP-1 access with oral and injectable options
Editorial score · methodology
Remote Pharmacy at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $167/mo (as low as 167/mo; injectable or sublingual, cash-pay)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Remote Pharmacy
Each dimension is scored algorithmically from Remote Pharmacy’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $167/mo, Remote Pharmacy runs in line with the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.8/10Remote Pharmacy offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.0/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
7.6/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-07-16).
Accessibility10%
5.7/10Remote Pharmacy's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.5/10Remote Pharmacy provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Remote Pharmacy review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Remote Pharmacy offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
as low as 167/mo; injectable or sublingual, cash-pay
as low as 229.99/mo; injectable or tablet
Ready to get started?
Plans and promotions change often — check Remote Pharmacy's current pricing and active discounts before you decide.
What we like
- Low cash-pay pricing with no subscription or hidden fees
- Free doctor consultation and free shipping (you pay only for medication)
- Offers injectable and sublingual or tablet forms of both drugs
- Medication made by 503A-certified compounding facilities
Watch-outs
- Does not publicly name its specific compounding pharmacies or clinical provider
- Covered states are not listed on the pages reviewed
- Newer brand with limited third-party track record
Is Remote Pharmacy worth it? Our verdict
Remote Pharmacy positions itself around one thing: people who want low cash-pay compounded glp-1 with no subscription and free shipping. It runs $167/month, flat across every dose. Its standout is a needle-free oral option, which very few providers offer.
On top of the prescription itself, Remote Pharmacy points to Sublingual option, Cash-pay, and No subscription.
How much Remote Pharmacy actually costs
- Compounded semaglutide — $167/month
- Compounded tirzepatide — $229.99/month
That's roughly in line with the ~$170/month median across the GLP-1 providers we track.
For a direct comparison, SkinnyRx runs semaglutide and tirzepatide from $149.25/month — worth pricing against Remote Pharmacy before you commit.
Medications: what Remote Pharmacy prescribes
Remote Pharmacy prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Remote Pharmacy's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who Remote Pharmacy is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Remote Pharmacy dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Remote Pharmacy is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Remote Pharmacy is a solid telehealth option with balanced features and pricing.
Ready to start with Remote Pharmacy?
Starting at $167/month. See current pricing and start your free consultation.
Remote Pharmacy might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Remote Pharmacy review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Remote Pharmacy's current pricing
Plans start at $167/month. Start your free consultation to check eligibility and today's price.